Selvita - your integrated drug discovery partner of choice

The largest drug
discovery company
in the CEE region

Your integrated drug
discovery partner of choice

Developing breakthrough
therapies in oncology

Delivering comprehensive
research solutions to biotech
and pharma

Krakow, Poland – 03 October – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines...

Krakow, Poland – 02 October – Selvita will participate and present at the upcoming 18th Annual Biotech in Europe Forum, which...

Krakow, Poland - 24 September – Selvita will participate as a panelist at the "Charting Poland's Future Event: Spotlight on Growth...

Krakow, Poland – 13 September 2018 – Selvita will present and exhibit at the upcoming Medicinal Chemistry Summit: USA, which...

Krakow, Poland – 11 September 2018 – Selvita, one of the largest drug discovery companies in Europe, has recently published...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.

54,00 PLN More

We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.